Midazolam suppresses thrombin-induced heat shock protein 27 phosphorylation through inhibition of p38 mitogen-activated protein kinase in cardiac myocytes

Journal of Cellular Biochemistry

Volumn 96, Issue 1, 2005, Pages 56-64

  Tanabe, Kumiko ^a   Akamatsu, Shigeru ^a   Suga, Hidetaka ^a   Takai, Shinji ^a   Kato, Kanefusa ^b   Dohi, Shuji ^a   Kozawa, Osamu ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

Cardiac myocyte; Heat shock protein 27; Midazolam; p38 mitogen activated protein kinase; Preconditioning; Thrombin

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANESTHETIC AGENT; CHAPERONE; HEAT SHOCK PROTEIN 27; MIDAZOLAM; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SERINE; STRESS ACTIVATED PROTEIN KINASE; THROMBIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANESTHETICS, INTRAVENOUS; ANIMALS; HEAT-SHOCK PROTEINS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MIDAZOLAM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; THROMBIN;

EID: 26444443135     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20455     Document Type: Article

References (34)

1. + exchanger activity: Signalling and significance. Cardiovasc Res 57:942-952.
2. Barvais L, Heitz D, Schmartz D, Maes V, Coussaert E, Cantraine F, d'Hollander A. 2000. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: Assessment of the prospective predictive accuracy and the quality of anesthesia. J Cardiothrac Vasc Anesth 14:402-408.
3. Benjamin IJ, McMillan DR. 1998. Stress (heat shock) proteins: Molecular chaperones in cardiovascular biology and disease. Circ Res 83:117-132.
4. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
5. ATP channel opening. Am J Physiol Heart Circ Physiol 282:H1961-H1969.
6. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233.
7. Fu X-B, Yang Y-H, Sun T-Z, Chen W, Li J-Y, Sheng Z-Y. 2003. Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injury. World J Gastroenterol 9:1312-1317.
8. Gaestel M, Schroder W, Benndorf R, Lippmann C, Buchner K, Hucho F, Erdmann VA, Bielka H. 1991. Identification of the phosphorylation sites of the murine small heat shock protein hsp25. J Biol Chem 266:14721-14724.
9. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K. 1997. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96:3737-3744.
10. Heide RSV. 2002. Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 282:H935-H941.
11. Inaguma Y, Goto S, Shinohara H, Hasegawa K, Ohshima K, Kato K. 1993. Physiological and pathological changes in levels of the two small stress proteins, HSP27 and αB crystallin, in rat hindlimb muscles. J Biochem 114: 378-384.
12. Kacimi R, Chentoufi J, Honbo N, Long CS, Karliner JS. 2000. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: Role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 46:139-150.
13. 2+ transients and contraction in adult rat ventricular myocytes. Anesth Analg 95:1637-1644.
14. Kato K, Hasegawa K, Goto S, Inaguma Y. 1994. Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, hsp27. J Biol Chem 269: 11274-11278.
15. Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O, Asano T. 1996. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem 66:946-950.
16. Kato K, Ito H, Kamei K, Iwamoto I, Inaguma Y. 2002. Innervation-dependent phosphorylation and accumulation of αB-crystallin and Hsp27 as insoluble complexes in disused muscle. FASEB J 16:1432-1434.
17. Kummer JL, Rao PK, Heidenreich KA. 1997. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272: 20490-20494.
18. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
19. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. 1990. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76:1-16.
20. Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH. 1997. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 96:4343-4348.
21. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
22. Sabri A, Muske G, Zhang H, Pak E, Darrow A, Andrade-Gordon P, Steinberg SF. 2000. Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res 86:1054-1061.
23. Sabri A, Guo J, Elouardighi H, Darrow AL, Andrade-Gordon P, Steinberg SF. 2003. Mechanisms of protease-activted receptor-4 actions in cardiomyocytes. J Biol Chem 278:11714-11720.
24. Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G. 2002. P38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55:690-700.
25. Shafer A. 1998. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 26:947-956.
26. Takenaka M, Matsuno H, Ishisaki A, Nakajima K, Hirade K, Takei M, Yasuda E, Akamatsu S, Yoshimi N, Kato K, Kozawa O. 2004. Platelet-derived growth factor-BB phosphorylates heat shock protein 27 in cardiac myocytes. J Cell Biochem 91:316-324.
27. Tanabe K, Kozawa O, Niwa M, Yamamoto T, Matsuno H, Ito H, Kato K, Dohi S, Uematsu T. 2002. Contrasting effects of midazolam on induction of heat shock protein 27 by vasopressin and heat in aortic smooth muscle cells. J Cell Biochem 84:39-46.
28. Tanabe K, Dohi S, Matsuno H, Hirade K, Kozawa O. 2003. Midazolam stimulates vascular endothelial growth factor release in aortic smooth muscle cells: Role of the mitogen-activated protein kinase superfamily. Anesthesiology 98: 1147-1154.
29. Teoh N, Pena AD, Farrell G. 2002. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase, and cell cycle entry. Hepatology 36: 94-102.
30. Welch WJ. 1985. Phorbol ester, calcium ionophore, or serum added to quiescent rat embryo fibroblast cells all result in the elevated phosphorylation of two 28,000-dalton mammalian stress proteins. J Biol Chem 260: 3058-3062.
31. Widmann C, Gibson S, Jarpe MB, Johnson GL. 1999. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180.
32. Zaugg M, Lucchhinetti E, Ueeker M, Pasch T, Schaub MC. 2003a. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 91:551-565.
33. Zaugg M, Lucchhinetti E, Garcia C, Pasch T, Spahn DR, Schaub MC. 2003b. Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth 91: 566-576.
34. Zheng S, Zuo Z. 2004. Isoflurane preconditioning induces neuroprotection against ischemia via activation of p38 mitogen-activated protein kinases. Mol Pharmacol 65: 1172-1180.